I bought IART today @ $34.50 & added to GERN
IART has been cut in half, down to a 9 PE going forward. This is because their Boston Factory was shut down for s few quarters. However with the factory expected to go back online this summer, with every other medical supply company selling for a 20+ PE going forward, I am with SS on this one, that it has great come back potential. The company is forecasting around 15% growth in 2024 over 2023, with $3.60 eps expected. Tack on even a 15 PE, and that takes the stock to $54, a 55% upside. I'm hopeful the company will get their Boston Factory back online this summer, and that the stock will start moving up quickly. I believe around $70-$75 is the potential over the next year, so a 100%+ potential.
Needless to say that GERN could go up 50%+ on the drop of a dime, with any PR of a potential partner, or buyout rumor, or early FDA approval. After the glowing ADCOM meeting last week, with a 12-2 vote, I believe this one will be a nice winner from here.